Figure 2 | Scientific Reports

Figure 2

From: MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis

Figure 2

MARC1 variant and clinical data in patients treated for at least 6 months for AIH without cholestatic overlaps (n = 146; A distribution of patients with normal or increased ALT in relation to the MARC1 genotype; B-D effects of this variant on serum AST, ALP and GGT). [GG], MARC1 wild-type; [GA], MARC1 heterozygous variant; [AA], MARC1 homozygous variant; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase; UNL, upper normal limit; MARC1, mitochondrial amidoxime-reducing component 1.

Back to article page